Skip to main content
. 2020 Jul 15;16(7):e1008560. doi: 10.1371/journal.ppat.1008560

Table 1. Features of cloned and functionally tested monoclonal antibodies.

Monoclonal antibodies derived from iDCgB immunized mice (DC, n = 4), HCMV infected mice (CV, n = 2), and iDCgB immunized and protected against HCMV (n = 3). Control antibodies SM5-1 and KIOVIG are shown as references. CB unit = cord blood units used for humanization. EC50 binding capacity to recombinant gB protein (μg/ml) was calculated for clones DC06, DC14 and DC16, PR28 and PR32. IC50 HCMV-neutralizing capacity (μg/ml) was calculated for clones DC06, DC16 and PR32. V, D and J genes depict top matches according to IgBLAST and IMGT nomenclature. Amino acid (AA) mutations include substitutions, insertions, and deletions. Characterictics of heavy chains are depicted.

AB # COHORT SUBJECT CB unit EC50 gB binding (μg/ml) IC50 NT (μg/ml) VH_GENE DH_GENE JH_GENE VH_IDENTITY CDRH3_AA CDRH3_AA_LENGTH CH_ISOTYPE
CV03 HCMV-Control Mouse-473 346 - - 3–30*18,3-30-5*01 3–10*02 6*03 98,3 AKPVRGVYYSYYMDV 15 3–1
CV04 HCMV-Control Mouse-475 346 - - 3–30*18,3-30-5*01 3–10*01,3–10*02,6–6*01 6*03 97,3 AKPPRSGYYYYYMDV 15 3–1
PR32 iDCgB-HCMV Mouse-1113 313 0.74 0,58 3–74*01 6–6*01 4*02 98,6 QCRSIADRRSPEFDY 15 2–1
PR35 iDCgB-HCMV Mouse-499 346 0.05 - 3–48*02 5–18*01,5–5*01 6*03 90,5 ARVTYSYGSPHQYYCMDV 18 1–1
PR28 iDCgB-HCMV Mouse-1113 313 - - 4–4*02 3–10*01 5*02 94,9 ARKPKVMVRGISDFFDP 17 1–1
DC06 iDCgB Mouse-1157 184 0.29 0,09 3–30*18,3-30-5*01 7–27*01 3*02 95,2 AKPFASGWGWVNAFDI 16 1–1
DC14 iDCgB Mouse-1254 229 0.004 - 1–46*01 2–2*01,2–2*03 4*02 98,3 ARGLRVYCSSSTCYATAGDY 20 2–1
DC16 iDCgB Mouse-1254 229 0.66 15,94 3–7*03 3–22*01 3*02 90,5 VRDRNYHEGSTYYDVFDI 18 1–1
DC17 iDCgB Mouse-1255 229 - - 1–46*01 4–17*01 4*02 91,6 ARDHGDYHFFDS 12 1–1
SM5-1 Reference - - 0,09 0,014 1–2*02 2–8*01 3*01 91,9 ARDGAKTVSNSGLSLLYYHNRLDA 14 -
Kiovig Reference - - 0,6 9,8 - - - - - - -